COMMUNIQUÉS West-GlobeNewswire

Cheetah Medical to Present at the European Society of Intensive Care Medicine 32nd Annual Congress
18/09/2019
NEWTON, Mass., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Cheetah Medical, a medical device leader in non-invasive fluid management technology, today announced the company will present at the European Society of Intensive Care [...]
Akari Therapeutics to Participate in Ladenburg Thalmann Healthcare Conference
18/09/2019
NEW YORK and LONDON, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where [...]
Microdermics Appoints Francis Duhay, MD, as Chief Executive Officer
18/09/2019
IRVINE, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Microdermics, Inc .™, a medical device company unlocking the potential of skin with an intradermal platform for biosensing and drug delivery applications, today [...]
Lantern Pharma CEO Panna Sharma to Showcase AI Platform at Drug Repositioning, Repurposing and Rescue Conference
18/09/2019
Presentation to highlight use of machine learning, genomics and AI in building Lantern's oncology drug portfolio and in developing insights about biological mechanisms, biomarker signatures and patient stratification [...]
Nkarta Therapeutics Promotes Nadir Mahmood, Ph.D., to Chief Business Officer
18/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held biopharmaceutical company developing engineered natural killer (NK) cell therapies to fight cancer, today announced [...]
REPEAT - AgraFlora Organics Awarded Cannabis Research License from Health Canada
18/09/2019
VANCOUVER, British Columbia, Sept. 18, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]
scPharmaceuticals Inc. Provides FUROSCIX® Update and Announces Completion of $20.0 Million Term Loan Agreement
18/09/2019
Continued progress on FUROSCIX; confirming the planned resubmission of FUROSCIX NDA with the FDA by mid-year 2020 Completed $20.0 Million Term Loan with Solar Capital Ltd. and Silicon Valley Bank BURLINGTON, Mass., Sept [...]
Better Choice Company Announces Voluntary Lock-Up Agreement with Management, Board of Directors and Key Shareholders
18/09/2019
Management, the Board and key shareholders represent approximately 20,000,000 shares or 32% of the fully diluted outstanding shares of the Company NEW YORK, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc [...]
Spectral Medical Rings the Bell at the Opening of the Toronto Stock Exchange
18/09/2019
TORONTO, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ( “Spectral” or the “Company” ) (TSX: EDT) , a Phase III company developing the first treatment for patients with septic shock guided by a companion [...]
Phase 2 Study Published in Ophthalmology Highlights Efficacy and Safety Data of Intravitreal APL-2 for Geographic Atrophy Secondary to Age-Related Macular Degeneration
18/09/2019
CRESTWOOD, Ky., and WALTHAM Mass., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (NASDAQ:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Vericel to Present at the Ladenburg Thalmann 2019 Healthcare Conference on Tuesday, September 24, 2019
18/09/2019
CAMBRIDGE, Mass., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Gerard Michel, CFO & [...]
PRA Health Sciences, Symphony Health Launch Metys(TM) National Market Measurement Tool
18/09/2019
The first of its kind, Metys(TM) delivers accurate, reliable data quickly through a single access point RALEIGH, N.C., Sept. 18, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the launch of [...]
Aravive to Present Late-Breaking Oral Presentation at European Society for Medical Oncology Congress 2019 in Barcelona
18/09/2019
Early Efficacy Data from Phase 1b/2 Study of AVB500 in Combination with Standard Chemotherapy in Patients with Platinum Resistant Ovarian Cancer to be Presented HOUSTON, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc [...]
MDBriefCase Group Announces New Expert Advisors and Transforms its Online Learning Platform
18/09/2019
TORONTO, Sept. 18, 2019 (GLOBE NEWSWIRE) -- MDBriefCase Group Inc. (“ MDBC ” or the “ Company ”), a global leader in e-learning products and services that aims to accelerate better decision-making in healthcare, [...]
MDBriefCase Group annonce de nouveaux conseillers experts et transforme sa plateforme de formation numérique
18/09/2019
TORONTO, 18 sept. 2019 (GLOBE NEWSWIRE) -- MDBriefcase Group Inc. (« MDBC » ou « l’ entreprise »), chef de file mondial en produits et services d’apprentissage de formation en ligne, vouée à l’amélioration et l’ [...]
ALR Technologies to Integrate with CGM Platforms
18/09/2019
ALRT’s comprehensive diabetes management system will soon integrate with existing continuous glucose monitoring (CGM) devices to drive improved patient outcomes RICHMOND, Va., Sept. 18, 2019 (GLOBE NEWSWIRE) -- ALR [...]
Artelo Biosciences Cannabidiol (CBD) Studies Referenced in September Issue of Nature Medicine
18/09/2019
LA JOLLA, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL) , a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, announced today [...]
HealthLynked Corp. Announces the Addition of Shawn Miller M.D. to its Medical Advisory Board
18/09/2019
NAPLES, Fla., Sept. 18, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK ), a nationwide healthcare network focused on improving healthcare through technology that connects doctors, patients and medical data, is [...]
New Data Presented on Blood Volume at Annual Heart Failure Society Meeting Amid Call to Broadly Adopt Daxor’s Diagnostic Technology
18/09/2019
NEW YORK, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today [...]

Pages